Activity Of Difloxacin Against Bacteria Isolated from Canine Otitis
WSAVA 2002 Congress
*Maria Teresa Tejedor Junco, José Luis Martín Barrasa, Manuel Morales Doreste, Pablo Lupiola Gómez, Zoilo González Lama
*Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria
Las Palmas de Gran Canaria, Canary Islands, ES
tejedor@vet.ulpgc.es

OBJECTIVES

Difloxacin is a difluorinated quinolone approved only for veterinary use. It has a wide spectrum of activity being active against a wide range of Gram negative and Gram positive veterinary pathogens. Difloxacin is indicated for the management of canine bacterial infections in the urinary tract, the respiratory tract and the skin.

The aim of this study was to investigate the in vitro antibacterial activity of difloxacin against bacteria isolated from canine otitis.

MATERIALS

Otitis samples were obtained from different clinics of Gran Canaria. Samples were cultured onto Agar McConkey, Blood Agar and Agar Sabouraud. Gram negative, oxidase negative strains were identified by API 20E system; Gram negative, oxidase positive strains were identified by API 20NE system. Catalase and coagulase tests were used to identify Gram positive bacteria.

Minimal Inhibitory Concentrations (MICs) were calculated by twofold dilution method on Isosensitest Agar using a Steer's replicator. Concentrations of antibiotic range from 128 mg/L to 0.06 mg/L.

RESULTS

MIC50 values of difloxacin were 0.125 mg/L for E. coli, 0.5 mg/l for Proteus mirabilis, 1 mg/L for Pseudomonas and 0.25 mg/L for Staphylococcus intermedius. MIC90 values were 128 mg/L for E. coli, 1 mg/L for P. mirabilis, 16 mg/L for Pseudomonas and 2 mg/L for Staphylococcus intermedius. Ranges of CMIs obtained were from 0.06 to >128 mg/L for E. coli; from 0.06 to 1 mg/L for P. mirabilis; from 0.06 to 32 mg/L for Pseudomonas and from 0.25 to 4 mg/L for Staphylococcus intermedius. MIC50 and MIC90 values are defined as concentrations at which 50% and 90% of the isolates are inhibited respectively.

Pseudomonas showed the higher percentage of resistant strains (35%, n = 54). Similar percentages of resistant strains were found for E. coli (13%, n = 15) and Staphylococcus intermedius (12.5%, n = 48). All the strains of Proteus mirabilis (n = 21) tested were susceptible to difloxacin.

CONCLUSION

Difloxacin showed a broad spectrum of activity against bacteria isolated from canine otitis. This fluoroquinolone could be useful for the treatment of canine otitis caused by Enterobacteriaceae or Staphylococcus intermedius but not for otitis due to Pseudomonas infection.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

José Luis Martín Barrasa
Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria

Manuel Morales Doreste
Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria.

Maria Teresa Tejedor Junco
Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria
P.O. Box 550
Las Palmas de Gran Canaria, Canary Islands 35080 ES

Pablo Lupiola Gómez
Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria.

Zoilo González Lama
Facultad de Veterinaria. Universidad de Las Palmas de Gran Canaria.


MAIN : : Difloxacin for Canine Otitis
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27